The partnership will significantly strengthen Ireland’s position within the European pharmaceutical research and innovation space.
Research Ireland’s Rinn Pharma & Biopharma, which is Ireland’s national centre for research and innovation in the manufacturing of medicines, has today (7 August) announced the institution is to be included in the NordicPharmaTrain (NPT) network.
NPT is a European research and training network that connects academic and industry partners with the aim of advancing pharmaceutical innovation. The network supports collaborative research, researcher mobility and interdisciplinary training, as a means of developing the next generation of scientists and strengthening Europe’s pharmaceutical research ecosystem.
Rinn Pharma & Biopharma’s inclusion will enhance NPT’s network of research institutions and industry collaborators, strengthening cross-border collaboration and accelerating scientific progress within the larger pharmaceutical sector.
As part of the collaboration, Rinn Pharma & Biopharma will host visiting researchers and PhD students, providing them with access to state-of-the-art laboratories, infrastructure and training, with the aim of supporting skills development, as well as academic and industry engagement.
